Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov;75(5):1248-1249.
doi: 10.1016/j.jhep.2021.06.004. Epub 2021 Jun 12.

Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?

Maria-Carlota Londoño  1 , Jordi Gratacós-Ginès  2 , Joaquín Sáez-Peñataro  3
Affiliations
Comment

Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?

Maria-Carlota Londoño et al. J Hepatol. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interests The authors declare not conflict of interests related to this manuscript. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment in

Comment on

References

    1. Bril F., Al Diffalha S., Dean M., Fettig D.M. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol. 2021;75:222–224. doi: 10.1016/j.jhep.2021.04.003. - DOI - PMC - PubMed
    1. Sasaki T., Suzuki Y., Ishida K., Kakisaka K., Abe H., Sugai T., et al. Autoimmune hepatitis following influenza virus vaccination: two case reports. Med (United States) 2018;97:e11621. doi: 10.1097/MD.0000000000011621. - DOI - PMC - PubMed
    1. Berry P.A., Smith-Laing G. Hepatitis A vaccine associated with autoimmune hepatitis. World J Gastroenterol. 2007;13:2238–2239. doi: 10.3748/wjg.v13.i15.2238. - DOI - PMC - PubMed
    1. Segal Y., Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol. 2018;15:586–594. doi: 10.1038/cmi.2017.151. - DOI - PMC - PubMed
    1. Sinigaglia F., Hammer J. Defining rules for the peptide-MHC class II interaction. Curr Opin Immunol. 1994;6:52–56. doi: 10.1016/0952-7915(94)90033-7. - DOI - PubMed

Substances